PerkinElmer has announced the U.S. release of an assay that could aid in the early detection of preeclampsia, a potentially fatal illness affecting pregnant women and their babies during the first trimester. The test, called PreeclampsiaScreen, evaluates a patient's risk for early-onset preeclampsia by identifying the presence of three biomarkers in blood samples.

Related Summaries